FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry, in particular to an antigenic composition comprising an effective amount of a mycobacterial antigenic Mycobacterium tuberculosis polypeptide for use in treating, suppression or prevention of mycobacterial infection in a patient, as well as a method for production thereof. Also disclosed is a diagnostic method in vitro mycobacterial infection involving using said composition. Invention also relates to a method of treating, suppressing or preventing mycobacterial infection in a patient, comprising administering to said patient said antigenic composition.
EFFECT: invention enables effective treatment, suppression or prevention of mycobacterial infection in a patient.
15 cl, 4 dwg, 4 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
| CHIMERIC ANTIGEN RECEPTOR | 2018 |
|
RU2770002C2 |
| FMDV RECOMBINANT VACCINES AND USE THEREOF | 2015 |
|
RU2745373C2 |
| THERAPEUTIC ANTI-CANCER NEOEPITOPE VACCINE | 2017 |
|
RU2782422C2 |
| DISPLAY OF AN INTEGRAL MEMBRANE PROTEIN ON EXTRACELLULAR ENVELOPED POXVIRUS VIRIONS | 2017 |
|
RU2759846C2 |
| CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) FOR CANCER TREATMENT | 2019 |
|
RU2811466C2 |
| CD3-BINDING DOMAIN | 2015 |
|
RU2742691C2 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
| MUC16-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USE | 2019 |
|
RU2795198C2 |
